$SIVE is the next SIVE. Don’t think you’ll find another company. That’s qualified and likely primary/sole source with: - $JBL and other pluggable hyperscaler suppliers - Ayar and the $NVDA NVLink CPO ecosystems While being the foundational reference laser for $GFS and pluggable/CPO/NPO deployments. That hyperscalers like $AMD and others use, at current valuations. Even $POET buys $SIVE lasers and Poet is about the same valuation just off having one $50m purchase agreement. Amount of hyperscaler suppliers for 2027 into 2028 is just ridiculous. From the general meeting today in a few hours, we’ll hopefully see NASDAQ listing timelines confirmed. So they can have room for M&A to TAM expansion and to make each laser they sell more valuable. Following what $LITE did to grow into a $75B company.
This is gonna upset a lot of people: But TA is astrology for traders. It's confirmation bias + trading human psychology about entries. Kinda like how people frontran $SPCE from $SPCX IPO expecting retail to mess up tickers by trading psychology. $SIVE didn't go up 1900% because of the golden cross space comet firebreathing dragon candle that someone is trying to sell for $499. It's because markets are pricing in future revenue from $JBL, $GFS that got announced. $AXTI didn't go up 8000% because the golden waterfall candle alert sounded back at $8. it's because of InP substrate, game theory on ASP hikes, export controls, photonics demand, and others. If you want to figure out psychologically what other regards are believing, you use TA. But for determining the actual upside... nah People have been drawing $120+ TAs on $IREN for the past idk how many months none of that crap matters when there's a $6B ATM that needs to be bought through first. It's by theme (eg. $LITE to $AAOI relations), any news catalysts that affect forward revenue, projections, macro news, earnings, float dynamics, and so on. Then you can just derive what MC that company should be at. So for entry points, sure you can use TA. For determining where the stock heads, just throw the tyrannosaurs rex omega-green candle indicator out the window.
Why do I keep getting these questions!!! $XFAB is building a Silicon Photonics foundry alternative to $TSEM and $GFS. And has Europe backing it + $NVDA evaluations. It takes time... Like October 2026, should finish up development. Then 2027 production scaled into 2028 (mass production), since they've been working on it since 2023. Everyone thinks it’s a depressed automaker supplier right now. And thankfully with European names they tend to look at TTM revenue over forward growth. So somehow it’s leading EU’s efforts to create a $TSEM silicon photonics foundry + supply chain at ~€1.1B MC? That R&D directors from ASE cite + others as future CPO routes. I’m might just really early to a lot of things, but of course most of the risk/reward comes from taking a little leap of faith in seeing it commercialized. Otherwise people can take the de-risked route with Tower directly (which I also wrote a thesis on awhile back and also like).
Names like: - $ASX - Sumitomo Electric - $JBL - $VICR - $GFS - $AAOI - AlChip - $TSEM - $FN - Furukawa Electric - $CLS - $NBIS - $NOK - $AMKR - $LITE - $COHR Off the top of my head. So basically, AI exposure trading in the $10-100B range. Likely have compelling ROI right now compared to indexes or $ARM to $MRVL that ran quite a bit? (Just a disclosure, only have financial interest in NBIS/TSEM/AAOI above) I mention a lot of smaller ideas, but that’s just to chase outsized returns. Still feels like many of these have room to go.
$SIVE is my favorite CPO / photonics stock after AAOI. Partly because it's Swedish and you have entertainment from comedians over there. Today a new non-technical hedge fund called Protean Funds (likely shorting), went on air. To said $SIVE CPO applications are imaginary. Right after $GFS just made $SIVE their reference laser. (Just for some context to newer readers: Lot of people in Sweden can only look at past 12 month revenue, and don't understand concepts of forward growth) Also because they don't understand that no CPO application has scaled up yet at all. So Swedish hedge funds keep going short (with many of their hedge funds like Colosseum / Origo heavily underwater). But... for the technical readers... from H2 2026 to 2028, it goes from near $0 to $91B TAM in 1 1/2 years. (we're entering H2 now). Overall TAM hits $141B (which is also 10x+ or so in 1 1/2 years)... and $SIVE has scaled into pluggable market with $JBL + other unnamed pluggable players with that too. Probably not going to end well for the local Swedish firms, shorting right before the largest inflection points ever hits for $SIVE. Just a matter of time before volume ramps.
$SIVE looks like both a chokepoint and a bottleneck for CPO next year. Keep seeing information published from nontechnical people who miss any nuances. Here’s the reason why: 1. CW lasers are bottlenecked signaled by $LITE earnings. Laser fabs are heavily allocated to EML likely from former $NVDA contracts. -> Sumitomo/Furukawa = bottleneck -> Win Semi = bottleneck $SIVE does fab-lite, so are they a bottleneck? Yes, $SIVE sits in the laser bottleneck since control output supply of CW lasers from Win Semi and other fabs from allocation way early on (CEO stated they working with more capacity from other players as well). Perfect example is Kioxia/Sandisk. $SNDK controls NAND output, so they’re a bottleneck because they control final pricing. Demand exceeding supply from Ayar, Jabil, other pluggable vendors + Nvidia NVLink CPO ecosystem… final laser supply owned by $SIVE makes Sivers a bottleneck. $SIVE is also likely primary/sole source for Jabil, Gen-1 Ayar, $MRVL Celestial, and other hyperscaler asic/merchant CPO routes. So no way to get around it (can’t hot-swap single channel cw lasers with Sivers) 2. $SIVE is a chokepoint over CPO. $NVDA use $COHR, $LITE (which likely sources external cw capacity from Japanese competitors) $AVGO is likely vertically integrated as well. However: the entire ecosystem around it from ASIC programs (Marvell, AlChip, etc) and merchant programs (Ayar, Lightmatter, Lightelligence) Are all likely designed around $SIVE. Ayar for example, likely tried to multi-source with $MTSI / $LITE back in 2022 but their lasers probably couldn’t match the level of Sivers specification with arrays (removed Lumentum / Macom from their supply chain site recently) If there’s no alternative at least for the initial generations (obviously they’re working to multi-source). That makes $SIVE a structural chokepoint to go through for lasers. Even if you look at the 1.6T LRO $JBL designed, they achieved a “drastic moat” with performance built around $SIVE likely sole source. $SIVE is also the foundry level reference laser design for $GFS, which your hyperscalers use like $AMD (likely using Sivers + maybe Ayar for gen1): If every major player, who hasn’t achieved vertical integration (Nvidia/Broadcom) is using Sivers for CPO… That makes them a chokepoint. Just look at the entire CPO $NVDA NVLink ecosystem partners: every single one are all likely using Sivers. And they all use $GFS as well (where Sivers is default reference). So $SIVE is both a chokepoint and bottleneck when CPO really scales up H2 2027, over one of the biggest architectural shifts of all time (near $0 -> $81B or $91B TAM in the next 1 1/2 years from GS research note) This is why I say $SIVE looks like it could be the next $75B $LITE over the next couple years. All of this should play out next year. And it’s still trading less than a company with $50M in purchase agreements that buys Sivers lasers to repackage them.
-> IP acquisition -> Just waiting for CPO to take off $SIVE is a laser chokepoint for photonics and are publicly validated by: - $GFS (1 of 2 public laser suppliers with $LITE for CPO per presentation) - $JBL (“Relatively dramatic moat” for pluggables built with Sivers) - CHIPS ACT for the overall company For highest visibility: -> Ayar is the largest CPO player that primary sources $SIVE and are expected to ramp in 2027. -> $POET is another near term CPO volume player that’s heavily visible with Sivers. For OSINT mapping: $MRVL Celestial (direct, not through Poet), Lightmatter, Lightelligence, were all high confidence customers of Sivers. $SIVE is also developing/qualifying with multiple more optical transceiver players following Jabil. It feels like they’re going to end up everywhere. I’m not sure people realize how special that many qualifications is coming from a <$2B MC laser company is… right before 2027 volume ramp. Especially while all the other laser companies trade at $15B-$70B valuations. Just need pluggables to bridge revenue gap into H2 2027 (CPO Scale up) Then making every laser they sell more valuable following the $LITE playbook, to capture more TAM of both markets. - In the overarching optical $141B TAM (10x) in the next 1 1/2 years. (Goldman Sachs) - and CPO TAM going from 0 to $81B in the next 1 1/2 years. So, easily multiply revenue opportunity overnight doing IP acquisition downstream. It’s more of just a waiting game, I think $SIVE is very undervalued relative to forward revenue potential. If it were a private Silicon Valley startup it would probably be worth $4-6B today. Just needs to get listed on NASDAQ for premiums to bridge that gap.
Just some mobile shower thoughts around $XFAB and train of thought: 1. 800vdc $NVDA push look for GaN/SiC players / power semis. 2. $NVTS and other fabless/fab-lite beneficiaries of $NVDA push probably use foundry models 3. care more about Western supply chains over Asia, want to build up Western capabilities + Western premiums. 4 China has a lot of capacity, maybe risk into 2028, but again it’s building up Western supply chains 5. XFAB only high volume SiC foundry in America (others like $ON or Infineon are vertically integrated) 6. advanced 6in SiC, 8in GaN on Si, building out 8in GaN 7. Maybe likely they’re developing 8in SiC from CHIPS backing, just not public material 8. check SiC revenue -> 152% Y/Y growth okay. Probably something markets missed, since blended looks worse from automotive slump, that should come out recovery 9. $NVTS and others turns out to use $XFAB. $POWI cites $XFAB in filings, among others. 10. both are $NVDA power semi explicit partners, great exposure indicator to 800vdc power semi players. 11. US Dpt. of commerce cites $XFAB as only high volume SiC foundry in the US, $50M PMT 12. validation from US Gov about critical component in supply chains is amazing 13. EU CHIPS Act gives $XFAB $128M EU, for foundry (MEMS, AI, etc), okay turns out they’re critical MEMS player 14. So that’s validation from EU gov about critical component in supply chains, dual continent subsidies 15. So now we know $XFAB is a critical MEMS foundry so you get SiC capabilities, GaN development, and MEMS upside 16. they also got $47.6M EU funding for leading Silicon Photonics supply chain in EU. So that’s EU funding on multiple angles. 17. Turns out, I know all the players there from smartphotonics from $GFS deck. 18. $NVDA and $NOK are qualifying them for silicon photonics HVM. I think this is just a government backing angle for success in EU photonics so likely to succeed… kinda like how Us gov encourages everyone to use $INTC. 19. Okay chips act 2 is coming out next week… so they’ll probably get funding there or more revenue commitments 20. 1.28 p/b, now that’s probably just book cost? Likely coming out of $SOI type legacy drag cycle. 21. Did some modeling around actually replacement values, true replacement p/b cost likely ~.5/.7. 22. Getting business for free, while having upside from SiC near term into Silicon Photonics / GaN as main growth past H2 2027. Thoughts: derisked by p/b values + replacement value. maybe like 20% downside from macro. However, critical dual continent importance. So downside risk seems low, but upside is compelling. Lot of capex likely backstopped by upcoming chips act catalyst + national security concerns. Maybe 2.5-4x rerating seems possible/likely. Not a 10-20x, but recovery from depressed valuations from silicon photonics upside with SiC / GaN bridge. TLDR: likely trading lower than replacement value, dual continent subsidies likely subsidize capex. Gov grants shows importance to Western supply chains, photonics longer term upside, SiC/GaN demand likely near term upside and bridge. Don’t control any recent volatility, should shake out anyone not really confident in the thesis though. CHIPS act 2 from EU is coming up, $XFAB was listed in earlier blueprints for optical ecosystem, so should get a boost after that comes out as near term event catalysts. So now is the risk reward seems compelling, we’ll see if this is right or not
$SIVE is the most compelling CPO/photonics exposure to me. Addressing the disinformation: I haven’t sold and don’t plan to sell a single share. I do think this ends up the next $80B+ $LITE one day from ~$2.1B. And I personally have plans to acquire more ownership + support their M&A prospects. I believe earnings transcripts will be strongly positive. As in the part few months we’ve discovered: > AlChip/Amazon private placements, which is positive for Ayar -> $SIVE implying Trainium 4 design in > Wiwynn + Ayar CPO scale up > $JBL 1.6T optical transceiver ramp with Sivers incoming faster than markets expected (with relatively dramatic moat + demand as much as they can produce) > O-Net scaling up ELS efforts with $SIVE > $YSS acquisition of $SIVE allspace lead partner, designing Sivers into Space defense primes > New CHIPS ACT funding for $SIVE > $POET H2 volume ramp and their new $50m -> $500m order (with $SIVE as light source) > information discovery around $AAPL using $SIVE lasers for next gen consumer devices > information discovery around links to Lightelligence (went public $10B+ MC) + Lightmatter as likely customers. > Celestial volume ramp with $MRVL indicators. > new customers working on TFLN with $SIVE like Lightium > $AMD going with $GFS for CPO, and GFS listing sivers as one of two laser suppliers > Ayar removing $MTSI / $LITE from their website and signaling $SIVE as primary source/sole source > Ayar raising $500m for volume ramp (intel, Mediatek, Nvidia, amd etc) > pluggable TAM expansion signaled from 2025 annual report > Nasdaq listing expected soon > MSCI small cap index / Nasdaq omx inclusion, making Blackrock, Vanguard and others passive buyers > M&A signaled from 2025 annual report + 2 new board members that have experience in that area > $NOK as likely customer from 2025 annual report. > $LITE getting cw bottlenecked from EML contracts, $SIVE signaling capacity agreements in place with Win, making the a likely bottleneck owner + chokepoint in CPO sector. All of this market research was done before earnings. Any results is just confirmation of supply chain mapping done. I don’t think anyone cares about former quarter revenue since $SIVE is an exceptionally compelling 2027 long, especially H2 onward. Only thing I’m looking at are: > TAM expansion of the overall photonics supercycle (eg. optical engine, ELS, pluggables) either from M&A or developments > volume ramp expectations from existing companies > Nasdaq listing timelines for more liquidity to support their M&A efforts > any new customers signaled for CPO/Pluggables
$SIVE is now aiming to become the next $LITE, a US photonics giant. They're re-centering their board around US executives + US photonics. So the core board are now: US $GFS Executives and $CITI Executives, with the company run by UC Berkeley grads and $LITE executives. The 3 members leaving were local Swedish/EU. This is just a shift in strategy from focusing on developing local Swedish Semi environments: To dominating the US/global photonics market. I'm not trying to discredit their service/background. But in my view to focus around US/global photonics markets, it's likely optimal to have more US executives. But they should all be proud for helping make $SIVE what it is today.
Random CPO related names I like: - $SIVE - Foci (3363) - $TSEM - Browave (3163) - PCL (4977) - $AXTI - Msscorps (6830) - $IQE - Shunsin (6451) - Furukawa Electric (5801) - $MTSI - Nextronics (8417) - $LITE - $COHR - FitTech (6706) - $GFS - $ASX - LandMark (3081) - $SOI Disclosure: I own most, not all though.